Concepts (210)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atherosclerosis | 4 | 2020 | 273 | 1.050 |
Why?
|
| Patient Selection | 2 | 2019 | 721 | 0.870 |
Why?
|
| Biomarkers | 3 | 2020 | 2020 | 0.850 |
Why?
|
| Macrophages | 3 | 2019 | 643 | 0.750 |
Why?
|
| Spironolactone | 1 | 2021 | 13 | 0.690 |
Why?
|
| Troponin T | 1 | 2020 | 42 | 0.640 |
Why?
|
| Monocytes | 2 | 2019 | 219 | 0.640 |
Why?
|
| Cytoskeleton | 4 | 2012 | 200 | 0.580 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2019 | 77 | 0.580 |
Why?
|
| Eligibility Determination | 1 | 2018 | 41 | 0.560 |
Why?
|
| Hypercholesterolemia | 1 | 2019 | 161 | 0.530 |
Why?
|
| Cardiology | 1 | 2019 | 125 | 0.530 |
Why?
|
| Antihypertensive Agents | 1 | 2018 | 273 | 0.480 |
Why?
|
| Heart Failure | 3 | 2021 | 1501 | 0.480 |
Why?
|
| Psoriasis | 1 | 2019 | 262 | 0.470 |
Why?
|
| Evidence-Based Medicine | 1 | 2018 | 481 | 0.460 |
Why?
|
| Anticoagulants | 1 | 2019 | 484 | 0.460 |
Why?
|
| Catheter Ablation | 1 | 2019 | 385 | 0.440 |
Why?
|
| Connective Tissue Diseases | 1 | 2016 | 76 | 0.440 |
Why?
|
| Risk Assessment | 2 | 2020 | 2598 | 0.430 |
Why?
|
| Blood Pressure | 1 | 2018 | 920 | 0.420 |
Why?
|
| Coronary Artery Disease | 1 | 2019 | 391 | 0.420 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 992 | 0.410 |
Why?
|
| Atrial Fibrillation | 1 | 2019 | 460 | 0.400 |
Why?
|
| Inferior Wall Myocardial Infarction | 1 | 2012 | 2 | 0.380 |
Why?
|
| Heart Aneurysm | 1 | 2012 | 16 | 0.370 |
Why?
|
| Hypertension | 1 | 2018 | 788 | 0.370 |
Why?
|
| Receptors, Immunologic | 1 | 2012 | 143 | 0.350 |
Why?
|
| Integrin beta1 | 3 | 2009 | 36 | 0.340 |
Why?
|
| Integrins | 4 | 2012 | 81 | 0.320 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 405 | 0.310 |
Why?
|
| Stress, Mechanical | 2 | 2009 | 251 | 0.310 |
Why?
|
| Heart Ventricles | 2 | 2021 | 664 | 0.300 |
Why?
|
| Membrane Proteins | 3 | 2013 | 1288 | 0.300 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2009 | 4 | 0.290 |
Why?
|
| Mechanotransduction, Cellular | 3 | 2009 | 91 | 0.280 |
Why?
|
| Signal Transduction | 5 | 2012 | 3627 | 0.280 |
Why?
|
| Nutrition Surveys | 2 | 2019 | 139 | 0.270 |
Why?
|
| Actin Cytoskeleton | 2 | 2012 | 201 | 0.270 |
Why?
|
| Humans | 23 | 2026 | 98223 | 0.260 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2013 | 114 | 0.260 |
Why?
|
| Risk Factors | 4 | 2020 | 6269 | 0.260 |
Why?
|
| Cholesterol | 2 | 2019 | 376 | 0.250 |
Why?
|
| Cells, Cultured | 6 | 2020 | 2856 | 0.220 |
Why?
|
| Microtubules | 1 | 2004 | 141 | 0.200 |
Why?
|
| Cell Membrane | 2 | 2013 | 675 | 0.200 |
Why?
|
| Calcium | 3 | 2006 | 1201 | 0.200 |
Why?
|
| Prevalence | 2 | 2019 | 1391 | 0.190 |
Why?
|
| Heart-Assist Devices | 2 | 2021 | 917 | 0.190 |
Why?
|
| Male | 9 | 2026 | 47195 | 0.180 |
Why?
|
| Age Factors | 2 | 2018 | 1972 | 0.180 |
Why?
|
| Treatment Outcome | 3 | 2021 | 9750 | 0.180 |
Why?
|
| Magnetics | 2 | 2004 | 39 | 0.170 |
Why?
|
| Middle Aged | 6 | 2021 | 29494 | 0.170 |
Why?
|
| Mineralocorticoid Receptor Antagonists | 1 | 2021 | 20 | 0.170 |
Why?
|
| Aged | 5 | 2021 | 21824 | 0.170 |
Why?
|
| Actins | 1 | 2004 | 480 | 0.170 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2020 | 7 | 0.170 |
Why?
|
| Vinculin | 1 | 2000 | 9 | 0.160 |
Why?
|
| Tetralogy of Fallot | 1 | 2021 | 47 | 0.160 |
Why?
|
| Female | 9 | 2026 | 51685 | 0.160 |
Why?
|
| Epithelial Cells | 1 | 2004 | 710 | 0.160 |
Why?
|
| Cilia | 3 | 2006 | 31 | 0.160 |
Why?
|
| Kidney | 2 | 2004 | 1121 | 0.160 |
Why?
|
| Gene Silencing | 1 | 2020 | 178 | 0.160 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 164 | 0.150 |
Why?
|
| Sensitivity and Specificity | 2 | 2021 | 1944 | 0.150 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 1784 | 0.150 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2021 | 116 | 0.150 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2019 | 67 | 0.140 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2021 | 161 | 0.140 |
Why?
|
| Cardiovascular Diseases | 1 | 2026 | 822 | 0.140 |
Why?
|
| Stroke Volume | 1 | 2021 | 464 | 0.140 |
Why?
|
| Electrocardiography | 1 | 2021 | 528 | 0.140 |
Why?
|
| American Heart Association | 1 | 2019 | 118 | 0.140 |
Why?
|
| NF-kappa B | 1 | 2020 | 423 | 0.130 |
Why?
|
| Ventricular Function, Left | 1 | 2021 | 540 | 0.130 |
Why?
|
| Creatinine | 1 | 2018 | 313 | 0.130 |
Why?
|
| Antigens, CD | 1 | 2019 | 484 | 0.130 |
Why?
|
| Adolescent | 3 | 2026 | 10127 | 0.130 |
Why?
|
| TRPP Cation Channels | 3 | 2006 | 17 | 0.130 |
Why?
|
| Health Status | 1 | 2018 | 388 | 0.120 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 304 | 0.120 |
Why?
|
| Focal Adhesions | 2 | 2009 | 67 | 0.120 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 477 | 0.120 |
Why?
|
| Prognosis | 2 | 2021 | 4126 | 0.120 |
Why?
|
| United States | 2 | 2019 | 8252 | 0.110 |
Why?
|
| Cattle | 3 | 2012 | 397 | 0.110 |
Why?
|
| Animals | 11 | 2020 | 28950 | 0.110 |
Why?
|
| Retrospective Studies | 2 | 2020 | 11031 | 0.110 |
Why?
|
| Comorbidity | 1 | 2018 | 1033 | 0.110 |
Why?
|
| Body Mass Index | 1 | 2018 | 867 | 0.110 |
Why?
|
| Young Adult | 2 | 2019 | 7556 | 0.110 |
Why?
|
| Cyclic AMP | 2 | 2009 | 277 | 0.110 |
Why?
|
| Pandemics | 1 | 2020 | 913 | 0.110 |
Why?
|
| Chemokine CCL2 | 1 | 2014 | 45 | 0.110 |
Why?
|
| Blood Glucose | 1 | 2018 | 914 | 0.100 |
Why?
|
| Heart Transplantation | 1 | 2021 | 873 | 0.100 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 1126 | 0.100 |
Why?
|
| Kidney Transplantation | 1 | 2021 | 942 | 0.100 |
Why?
|
| Adult | 3 | 2019 | 29548 | 0.100 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 1009 | 0.100 |
Why?
|
| Mice | 7 | 2020 | 12718 | 0.100 |
Why?
|
| Anion Exchange Protein 1, Erythrocyte | 1 | 2013 | 14 | 0.100 |
Why?
|
| Aquaporins | 1 | 2013 | 14 | 0.100 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 2012 | 0.090 |
Why?
|
| Blood Cells | 1 | 2013 | 32 | 0.090 |
Why?
|
| Heart Rupture, Post-Infarction | 1 | 2012 | 7 | 0.090 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 2 | 2006 | 147 | 0.090 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2012 | 18 | 0.090 |
Why?
|
| Polymerization | 1 | 2012 | 36 | 0.090 |
Why?
|
| Complement System Proteins | 1 | 2013 | 87 | 0.090 |
Why?
|
| Syncope | 1 | 2012 | 30 | 0.090 |
Why?
|
| Sex Factors | 1 | 2016 | 1142 | 0.090 |
Why?
|
| Chemotaxis | 1 | 2012 | 77 | 0.090 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2012 | 91 | 0.090 |
Why?
|
| Dyspnea | 1 | 2012 | 90 | 0.090 |
Why?
|
| Lipid Bilayers | 1 | 2013 | 148 | 0.090 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 269 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 731 | 0.080 |
Why?
|
| Endothelium, Vascular | 3 | 2009 | 440 | 0.080 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2012 | 179 | 0.080 |
Why?
|
| HEK293 Cells | 1 | 2012 | 718 | 0.080 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2013 | 327 | 0.080 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 2054 | 0.080 |
Why?
|
| Prospective Studies | 1 | 2018 | 4815 | 0.080 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 7409 | 0.070 |
Why?
|
| Aorta | 1 | 2009 | 275 | 0.070 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2009 | 176 | 0.060 |
Why?
|
| Models, Biological | 2 | 2012 | 1805 | 0.060 |
Why?
|
| Mice, Knockout | 3 | 2020 | 2209 | 0.060 |
Why?
|
| Epithelium | 2 | 2006 | 316 | 0.060 |
Why?
|
| Nocodazole | 1 | 2004 | 18 | 0.050 |
Why?
|
| Urban Population | 1 | 2026 | 249 | 0.050 |
Why?
|
| Health Behavior | 1 | 2026 | 202 | 0.050 |
Why?
|
| Microspheres | 2 | 2004 | 97 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 1 | 2004 | 122 | 0.050 |
Why?
|
| Neurons | 1 | 2013 | 1621 | 0.050 |
Why?
|
| Cytoplasm | 1 | 2004 | 276 | 0.050 |
Why?
|
| Cell Adhesion | 1 | 2004 | 420 | 0.050 |
Why?
|
| Extracellular Matrix | 1 | 2004 | 259 | 0.050 |
Why?
|
| Atrial Pressure | 1 | 2021 | 6 | 0.040 |
Why?
|
| Child | 2 | 2026 | 7730 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2026 | 1295 | 0.040 |
Why?
|
| Electronic Health Records | 1 | 2026 | 450 | 0.040 |
Why?
|
| Cardiac Output | 1 | 2021 | 142 | 0.040 |
Why?
|
| Chicago | 1 | 2026 | 1519 | 0.040 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2021 | 24 | 0.040 |
Why?
|
| Cholesterol, Dietary | 1 | 2020 | 27 | 0.040 |
Why?
|
| Diastole | 1 | 2021 | 101 | 0.040 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2020 | 75 | 0.040 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2021 | 123 | 0.040 |
Why?
|
| Calibration | 1 | 2000 | 109 | 0.040 |
Why?
|
| Homeostasis | 1 | 2003 | 474 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2026 | 2544 | 0.040 |
Why?
|
| Ventricular Function, Right | 1 | 2021 | 146 | 0.040 |
Why?
|
| Allografts | 1 | 2021 | 220 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2000 | 291 | 0.040 |
Why?
|
| Infant | 1 | 2026 | 3348 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2026 | 3217 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2000 | 1028 | 0.040 |
Why?
|
| Pulmonary Artery | 1 | 2021 | 342 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2026 | 4026 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2026 | 3030 | 0.030 |
Why?
|
| Proteins | 1 | 2003 | 803 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2021 | 581 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2021 | 2002 | 0.030 |
Why?
|
| Gene Expression | 1 | 2020 | 1321 | 0.030 |
Why?
|
| Echocardiography | 1 | 2021 | 783 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2000 | 1133 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 2789 | 0.030 |
Why?
|
| Receptors, CCR2 | 1 | 2014 | 34 | 0.030 |
Why?
|
| Graft Rejection | 1 | 2021 | 1186 | 0.030 |
Why?
|
| Micelles | 1 | 2014 | 56 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2014 | 111 | 0.030 |
Why?
|
| Pathology, Molecular | 1 | 2014 | 36 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2014 | 290 | 0.030 |
Why?
|
| Inflammation | 1 | 2020 | 1129 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 2014 | 139 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2004 | 2379 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 3612 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2014 | 994 | 0.020 |
Why?
|
| Binding Sites | 1 | 2014 | 1159 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 2003 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 1606 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 2894 | 0.020 |
Why?
|
| Biophysical Phenomena | 1 | 2004 | 126 | 0.010 |
Why?
|
| Biophysics | 1 | 2004 | 154 | 0.010 |
Why?
|
| Capillaries | 1 | 2004 | 86 | 0.010 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2003 | 24 | 0.010 |
Why?
|
| Tubulin | 1 | 2003 | 61 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2004 | 205 | 0.010 |
Why?
|
| Mutation | 2 | 2006 | 4408 | 0.010 |
Why?
|
| Base Sequence | 1 | 2006 | 2222 | 0.010 |
Why?
|
| Ligands | 1 | 2004 | 490 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 2003 | 150 | 0.010 |
Why?
|
| Temperature | 1 | 2004 | 442 | 0.010 |
Why?
|
| Caffeine | 1 | 2003 | 86 | 0.010 |
Why?
|
| Calcium Channels | 1 | 2003 | 180 | 0.010 |
Why?
|
| Heterozygote | 1 | 2003 | 390 | 0.010 |
Why?
|
| Protein Transport | 1 | 2003 | 447 | 0.010 |
Why?
|
| Physical Stimulation | 1 | 2000 | 49 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2000 | 94 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2004 | 502 | 0.010 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2000 | 64 | 0.010 |
Why?
|
| DNA | 1 | 2006 | 1274 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2000 | 119 | 0.010 |
Why?
|
| Protein Binding | 1 | 2003 | 1557 | 0.010 |
Why?
|
| Time Factors | 1 | 2004 | 5573 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2000 | 2020 | 0.010 |
Why?
|